A randomised controlled trial to investigate the effect of regular moderate intensity exercise on plasma fibrinogen in people with type two diabetes: a pilot study
ISRCTN | ISRCTN98564438 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN98564438 |
Secondary identifying numbers | N0249142478 |
- Submission date
- 30/09/2005
- Registration date
- 30/09/2005
- Last edited
- 12/09/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Rob Andrews
Scientific
Scientific
University of Bristol
Department of Exercise and Health Sciences
Tyndall Avenue
Bristol
BS8 1TP
United Kingdom
Phone | +44 (0)1823 344988 |
---|---|
rob.andrews@bristol.ac.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Treatment |
Participant information sheet | Not available in web format, please use contact details to request a participant information sheet |
Scientific title | A randomised controlled trial to investigate the effect of regular moderate intensity exercise on plasma fibrinogen in people with type two diabetes: a pilot study |
Study objectives | Does moderate intensity exercise modify plasma fibrinogen levels in people with type two diabetes? |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Type two diabetes |
Intervention | Randomised controlled trial |
Intervention type | Other |
Primary outcome measure | 1. Plasma fibrinogen 2. Plasminogen activator inhibitor-1 (PAI-1) |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 01/06/2003 |
Completion date | 06/10/2004 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Not Specified |
Sex | Both |
Target number of participants | 80 |
Key inclusion criteria | 80 patients with type two diabetes |
Key exclusion criteria | 1. Smokers 2. Taking drugs affecting clotting 3. Inability to exercise |
Date of first enrolment | 01/06/2003 |
Date of final enrolment | 06/10/2004 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
University of Bristol
Bristol
BS8 1TP
United Kingdom
BS8 1TP
United Kingdom
Sponsor information
Department of Health
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Phone | +44 (0)20 7307 2622 |
---|---|
dhmail@doh.gsi.org.uk | |
Website | http://www.dh.gov.uk/Home/fs/en |
Funders
Funder type
Government
Taunton and Somerset Research and Development Consortium (UK)
No information available
NHS R&D Support Funding (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
12/09/2016: No publications found, verifying study status with principal investigator.